Healthcare Press Micronesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Micronesia.

Press releases published on September 1, 2026

13 minutes ago

Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September

Indeterminate GlobeNewswire

13 minutes ago

STERIS to Present at the Morgan Stanley Healthcare Conference

Indeterminate GlobeNewswire

13 minutes ago

Cellectis annonce sa participation à plusieurs conférences investisseurs

Indeterminate GlobeNewswire

13 minutes ago

Cellectis Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

13 minutes ago

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

13 minutes ago

Tarsus to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

15 minutes ago

Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

28 minutes ago

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

33 minutes ago

LifeStance to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

38 minutes ago

Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

38 minutes ago

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

Indeterminate GlobeNewswire

38 minutes ago

Sana Biotechnology to Present at September 2026 Investor Conferences

Indeterminate GlobeNewswire

38 minutes ago

Cytek Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

38 minutes ago

CAMP4 to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

38 minutes ago

Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

38 minutes ago

Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journal of Inherited Metabolic Disease

Indeterminate GlobeNewswire

38 minutes ago

Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

38 minutes ago

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

38 minutes ago

BBOT to Participate in Upcoming Investor Healthcare Conferences

Indeterminate GlobeNewswire

38 minutes ago

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire